Labmaster Ltd, based in Turku, Finland, is a privately-owned company focusing on delivering innovative diagnostics tools for applications in routine clinical diagnostics and research. Labmaster develops and commercializes the next generation of versatile miniaturized detection tools based on its proprietary cathodic electrochemiluminescence-technology (LM-CECL). The superiority of LM-CECL technology allows it to overcome the performance limitations of previous generation’s tests relating to sensitivity, accuracy, easy to use and cost efficiency.
The Labmaster Lucia is the next generation diagnostics instrument for point-of-care blood tests. The compact instrument harnesses the breakthrough LM-CECL method to increase diagnostic speed and precision. Using the Lucia, medical professionals can easily perform diagnostics on site and obtain accurate results within five minutes at a fraction of the cost of existing methods. The Lucia allows simultaneous testing of multiple biomarkers from one blood sample, surpassing methods that require several samples. Blood diagnostics are a critical step in patient treatment, directing over half of all clinical decisions. Current options are often slow and costly: blood samples are sent to a laboratory with expensive, immobile equipment or tested on site with low-accuracy and limited devices. The growing healthcare sector demands efficient mobile instruments to enable rapid diagnosis in hospitals and small clinics.
The main advantage of this technology is cost-effectiveness achieved by replacing expensive optics with low priced sophisticated electronics. This technology is suitable for many kinds of laboratory instrumentation applications. Labmaster owns the immaterial property rights for this technology and has the strategy to protect further its findings related to new applications.
The feasibility study focused on the technical and commercial viability of new types of test assays for common conditions. The successful study resulted in a new test cartridge that improves the usability and value of the Lucia, and a commercialisation strategy to ensure it can achieve set sales targets which are presented as a full business plan.
